CME webinar: Suicide and Depression in the Primary Care Office (recorded)

Mar. 2023Education/Webinars
"What the webinar will cover*
  • Information on the prevalence of depression, suicide, and suicidal thoughts and behaviors from a state and national perspective
  • How to incorporate routine screenings for depression and suicide into daily practice
  • A multipronged approach in the treatment for depression and suicide in primary care
  • How to determine when and how to refer to behavioral health services
  • The spectrum of UPMC Health Plan resources that support behavioral health conditions

Presenters:
Geoff Neimark, MD
Chief Medical Officer
Community Care Behavioral Health Organization

Nicholas DeGregorio, MD, MMM, FACP
AVP, Medicaid Medical Services
UPMC Health Plan

Watch now
Watch the recording of the Suicide and Depression in the Primary Care Office webinar.

Provider is responsible for verifying continuing medical education (CME) eligibility.

*This activity is approved for AMA PRA Category 1.5 Credits™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity."

Recent Announcements

Important announcement – Telehealth submissions

As of October 1, 2025, UPMC Health Plan continues to accept the submission of telehealth claims. Providers may conduct telehealth visits for UPMC Health Plan members in all UPMC Insurance products. UPMC Insurance products include UPMC Advantage group and individual products, UPMC for Life Medicare Advantage plans, UPMC for Kids CHIP plans, UPMC Community HealthChoices, and UPMC for You Medical Assistance plans.
Sep. 2025Important Notices

October 2025 UPMC for You and UPMC Community HealthChoices Formulary Update

Effective October 1st, 2025, Xifaxan and Retin-A (cream, gel) will no longer be covered by UPMC for You and UPMC Community HealthChoices due to non-participation in the Medicaid Drug Rebate Program.
Sep. 2025Pharmacy Updates

Biosimilar Medication Formulary Updates

Updates to formulary biosimilar medications for denosumab, eculizumab, and ustekinumab products
Sep. 2025Pharmacy Updates